WallStreetZenWallStreetZen

NASDAQ: ACCD
Accolade Inc Stock

$7.48+0.15 (+2.05%)
Updated May 17, 2024
ACCD Price
$7.48
Fair Value Price
N/A
Market Cap
$586.11M
52 Week Low
$6.33
52 Week High
$15.36
P/E
-5.62x
P/B
1.32x
P/S
1.9x
PEG
N/A
Dividend Yield
N/A
Revenue
$414.29M
Earnings
-$99.81M
Gross Margin
46.4%
Operating Margin
-25.23%
Profit Margin
-24.1%
Debt to Equity
0.77
Operating Cash Flow
-$16M
Beta
2.35
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ACCD Overview

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ACCD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ACCD is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ACCD is good value based on its book value relative to its share price (1.32x), compared to the US Health Information Services industry average (3.33x)
P/B vs Industry Valuation
ACCD is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ACCD due diligence checks available for Premium users.

Be the first to know about important ACCD news, forecast changes, insider trades & much more!

ACCD News

Valuation

ACCD fair value

Fair Value of ACCD stock based on Discounted Cash Flow (DCF)
Price
$7.48
Fair Value
$13.83
Undervalued by
45.91%
ACCD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ACCD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-5.62x
Industry
9.15x
Market
30.97x

ACCD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.32x
Industry
3.33x
ACCD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ACCD's financial health

Profit margin

Revenue
$124.8M
Net Income
-$7.5M
Profit Margin
-6%
ACCD's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
ACCD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$788.2M
Liabilities
$342.7M
Debt to equity
0.77
ACCD's short-term assets ($284.91M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ACCD's short-term assets ($284.91M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ACCD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ACCD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$6.0M
Investing
-$53.3M
Financing
$3.0M
ACCD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ACCD vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
ACCD$586.11M+2.05%-5.62x1.32x
WGS$585.31M-6.79%-4.32x2.82x
WEAV$637.97M-1.75%-20.86x8.69x
TALK$466.63M-1.79%-34.38x3.90x
NRC$740.20M-2.64%24.80x20.04x

Accolade Stock FAQ

What is Accolade's quote symbol?

(NASDAQ: ACCD) Accolade trades on the NASDAQ under the ticker symbol ACCD. Accolade stock quotes can also be displayed as NASDAQ: ACCD.

If you're new to stock investing, here's how to buy Accolade stock.

What is the 52 week high and low for Accolade (NASDAQ: ACCD)?

(NASDAQ: ACCD) Accolade's 52-week high was $15.36, and its 52-week low was $6.33. It is currently -51.3% from its 52-week high and 18.17% from its 52-week low.

How much is Accolade stock worth today?

(NASDAQ: ACCD) Accolade currently has 78,356,908 outstanding shares. With Accolade stock trading at $7.48 per share, the total value of Accolade stock (market capitalization) is $586.11M.

Accolade stock was originally listed at a price of $30.00 in Jul 6, 2020. If you had invested in Accolade stock at $30.00, your return over the last 3 years would have been -75.07%, for an annualized return of -37.06% (not including any dividends or dividend reinvestments).

How much is Accolade's stock price per share?

(NASDAQ: ACCD) Accolade stock price per share is $7.48 today (as of May 17, 2024).

What is Accolade's Market Cap?

(NASDAQ: ACCD) Accolade's market cap is $586.11M, as of May 19, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Accolade's market cap is calculated by multiplying ACCD's current stock price of $7.48 by ACCD's total outstanding shares of 78,356,908.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.